Víctor Hernando

1.5k total citations
16 papers, 913 citations indexed

About

Víctor Hernando is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Emergency Medicine. According to data from OpenAlex, Víctor Hernando has authored 16 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Emergency Medicine. Recurrent topics in Víctor Hernando's work include Cardiac Ischemia and Reperfusion (12 papers), Cardiac Arrest and Resuscitation (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Víctor Hernando is often cited by papers focused on Cardiac Ischemia and Reperfusion (12 papers), Cardiac Arrest and Resuscitation (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Víctor Hernando collaborates with scholars based in Spain, Chile and Palestinian Territory. Víctor Hernando's co-authors include Javier Inserte, David García‐Dorado, David García‐Dorado, Ignasi Barba, Marcos Poncelas, J INSERTE, Jordi Soler‐Soler, Marisol Ruiz‐Meana, Carmem Luíza Sartório and José A. Barrabés and has published in prestigious journals such as Circulation, Circulation Research and Cardiovascular Research.

In The Last Decade

Víctor Hernando

16 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Víctor Hernando Spain 15 511 404 279 277 199 16 913
J INSERTE Spain 9 434 0.8× 351 0.9× 196 0.7× 269 1.0× 71 0.4× 13 711
Marcos Poncelas Spain 12 205 0.4× 243 0.6× 106 0.4× 156 0.6× 103 0.5× 14 509
K Kishi Japan 8 416 0.8× 496 1.2× 146 0.5× 123 0.4× 38 0.2× 11 887
Alberto Cabestrero Spain 10 412 0.8× 777 1.9× 199 0.7× 197 0.7× 31 0.2× 14 1.0k
Maryline Abrial France 14 185 0.4× 497 1.2× 73 0.3× 164 0.6× 139 0.7× 17 741
Christof Weinbrenner Germany 14 537 1.1× 333 0.8× 285 1.0× 329 1.2× 25 0.1× 22 926
Sophie Tamareille France 15 310 0.6× 302 0.7× 120 0.4× 220 0.8× 25 0.1× 20 694
Vishnu Undyala United States 11 216 0.4× 245 0.6× 75 0.3× 113 0.4× 130 0.7× 15 669
David Sontag Canada 10 355 0.7× 359 0.9× 189 0.7× 338 1.2× 26 0.1× 14 750
Siavash Beikoghli Kalkhoran United Kingdom 12 322 0.6× 610 1.5× 68 0.2× 190 0.7× 53 0.3× 18 898

Countries citing papers authored by Víctor Hernando

Since Specialization
Citations

This map shows the geographic impact of Víctor Hernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Hernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Hernando more than expected).

Fields of papers citing papers by Víctor Hernando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Hernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Hernando. The network helps show where Víctor Hernando may publish in the future.

Co-authorship network of co-authors of Víctor Hernando

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Hernando. A scholar is included among the top collaborators of Víctor Hernando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Hernando. Víctor Hernando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Poncelas, Marcos, et al.. (2017). Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling. Cardiovascular Research. 113(8). 950–961. 27 indexed citations
3.
Inserte, Javier, Víctor Hernando, Marisol Ruiz‐Meana, et al.. (2014). Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection. Cardiovascular Research. 103(4). 542–553. 26 indexed citations
4.
Ruiz‐Meana, Marisol, Estefanía Núñez, Elisabet Miró‐Casas, et al.. (2014). Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. Journal of Molecular and Cellular Cardiology. 68. 79–88. 45 indexed citations
5.
Inserte, Javier, et al.. (2013). Activation of cGMP/Protein Kinase G Pathway in Postconditioned Myocardium Depends on Reduced Oxidative Stress and Preserved Endothelial Nitric Oxide Synthase Coupling. Journal of the American Heart Association. 2(1). e005975–e005975. 55 indexed citations
6.
Inserte, Javier, Víctor Hernando, & David García‐Dorado. (2012). Contribution of calpains to myocardial ischaemia/reperfusion injury. Cardiovascular Research. 96(1). 23–31. 120 indexed citations
7.
Inserte, Javier, Ignasi Barba, Marcos Poncelas, et al.. (2011). cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. Journal of Molecular and Cellular Cardiology. 50(5). 903–909. 59 indexed citations
8.
Ruiz‐Meana, Marisol, Javier Inserte, Celia Fernández‐Sanz, et al.. (2011). The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia. Basic Research in Cardiology. 106(6). 1259–1268. 51 indexed citations
9.
Hernando, Víctor, et al.. (2010). Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion. Journal of Molecular and Cellular Cardiology. 49(2). 271–279. 88 indexed citations
10.
Barrabés, José A., Javier Inserte, Maribel Mirabet, et al.. (2010). Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts. Thrombosis and Haemostasis. 104(7). 128–135. 46 indexed citations
11.
INSERTE, J, José A. Barrabés, Víctor Hernando, & David García‐Dorado. (2009). Orphan targets for reperfusion injury. Cardiovascular Research. 83(2). 169–178. 39 indexed citations
12.
Inserte, Javier, Ignasi Barba, Víctor Hernando, & David García‐Dorado. (2008). Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovascular Research. 81(1). 116–122. 89 indexed citations
13.
Barrabés, José A., Javier Inserte, Maribel Mirabet, et al.. (2008). Abstract 1712: The P2Y 12 Antagonist Cangrelor and the GP IIb/IIIa Blocker Abciximab Reduce Platelet-Mediated Myocardial Injury After Ischemia and Reperfusion. Circulation. 118(suppl_18). 1 indexed citations
14.
INSERTE, J, Ignasi Barba, Víctor Hernando, et al.. (2007). Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovascular Research. 77(4). 782–790. 83 indexed citations
15.
INSERTE, J, et al.. (2006). Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion☆. Cardiovascular Research. 70(2). 364–373. 49 indexed citations
16.
Inserte, Javier, David García‐Dorado, Víctor Hernando, & Jordi Soler‐Soler. (2005). Calpain-Mediated Impairment of Na + /K + –ATPase Activity During Early Reperfusion Contributes to Cell Death After Myocardial Ischemia. Circulation Research. 97(5). 465–473. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026